Operating income for the fourth quarter of 2024 was $0.4 million, compared to $0.2 million for the same period in 2023. Adjusted EBITDA 1 for the fourth quarter of 2024 was approximately $1.4 million, ...

BrainsWay Ltd (BRSYF) reports a 27% revenue increase and outlines plans for continued growth and innovation in 2025.

Stelios Papadopolous, Ph.D., a pioneering leader in biotech, appointed to Board of Directors; two industry veterans joined ...

Medication-assisted treatment is an excellent approach to managing addiction and related emotional symptoms, Rachel Rohaidy, ...

WARREN — Beacon Light Behavioral Health System (BLBHS), an affiliate of Journey Health System, announced it is offering ...

A new accelerated theta-burst stimulation protocol may be a viable alternative to more intensive and costly neuromodulation ...

University of Iowa Health Care is among only three academic medical centers in the nation, and the first in the Midwest, to ...

Increased access to behavioral health care was associated with significant cost reductions, suggesting a financially viable buyer strategy.

The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple ...

Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...

An Idaho State University alumnus has returned to Pocatello to address the high demand for mental health services in the area ...